ब्रोमोक्रिप्टिन और रासाजिलिन का इंटरैक्शन

For this reason, prescribers should monitor patients for drowsiness or sleepiness, because some of the events occur well after initiation of treatment with dopaminergic medication.

Dyskinesia When used as an adjunct to levodopa, rasagiline may cause dyskinesia or potentiate dopaminergic side effects and exacerbate preexisting dyskinesia.

Patients with a major psychotic disorder should ordinarily not be treated with rasagiline because of the risk of exacerbating the psychosis with an increase in central dopaminergic tone.

In addition, many treatments for psychosis that decrease central dopaminergic tone may decrease the effectiveness of rasagiline [see Drug Interactions ( 7.8 )] .

…patients can experience intense urges to gamble, increased sexual urges, intense urges to spend money, binge eating, and/or other intense urges, and the inability to control these urges while taking one or more of the medications, including rasagiline, that increase central dopaminergic tone and that are generally used for the treatment of Parkinson’s disease.